Plasma unconjugated bile acids as novel biomarker for schizophrenia

Biochem Biophys Res Commun. 2022 Dec 17:634:70-74. doi: 10.1016/j.bbrc.2022.09.110. Epub 2022 Oct 4.

Abstract

In this study, we measured conjugated and unconjugated free bile acids (BAs) in plasma from patients with schizophrenia and healthy subjects to examine the possibility of BA as a biomarker for schizophrenia. Although the levels of each BA conjugate showed no significant differences, significant differences for three unconjugated bile acids were observed in the plasma between patients with schizophrenia and healthy subjects. Additionally, a more than three times difference between patients and healthy subjects was observed in the mean value of the total concentrations of primary BAs. These results indicate that cholic acid and chenodeoxycholic acid levels in plasma may be novel diagnostic markers for a sub-population of patients with schizophrenia. Thus, future studies should elucidate the relationship between this increase in BA levels and the pathology of schizophrenia and verify the potential of unconjugated BA in plasma as biomarkers for schizophrenia.

Keywords: Bile acid; Biomarker; LC-MS/MS; Plasma; Schizophrenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bile Acids and Salts*
  • Biomarkers
  • Chenodeoxycholic Acid
  • Humans
  • Plasma
  • Schizophrenia* / diagnosis

Substances

  • Bile Acids and Salts
  • Chenodeoxycholic Acid
  • Biomarkers